China is already gene-editing a lot of humans
A new report says at least 86 people have had their genes edited in China to help cure disease.
Backstory: We already knew that China had experimented with CRISPR gene editing in humans since 2016, becoming the first nation in the world to do so. But no human CRISPR trials have so far taken place in America.
What’s new: An investigation by the Wall Street Journal says that CRISPR gene editing has actually been used in Chinese hospitals to treat human diseases like cancer since 2015. The new report shows the extent of the trend.
How it’s possible: Unlike the US, China allows a hospital’s ethics committee to approve research on humans. CRISPR trials can be approved within an afternoon.
But: The push to use the technique isn’t necessarily a good idea. There are still safety concerns about such treatments, from immune reactions to unintended edits.
Deep Dive
Biotechnology and health
Google helped make an exquisitely detailed map of a tiny piece of the human brain
A small brain sample was sliced into 5,000 pieces, and machine learning helped stitch it back together.
The effort to make a breakthrough cancer therapy cheaper
CAR-T cells could revolutionize the treatment of a wide variety of diseases, if only we can make them cheaper.
That viral video showing a head transplant is a fake. But it might be real someday.
BrainBridge is best understood as the first public billboard for a hugely controversial scheme to defeat death.
Beyond Neuralink: Meet the other companies developing brain-computer interfaces
Companies like Synchron, Paradromics, and Precision Neuroscience are also racing to develop brain implants
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.